Astrana Health Inc. (ASTH)
Astrana Health, Inc. (ASTH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Astrana Health, Inc. (ASTH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Astrana Health, Inc. (ASTH) Q3 2025 Earnings Call Transcript
Astrana Health, Inc. ( ASTH ) Q3 2025 Earnings Call November 6, 2025 5:30 PM EST Company Participants Brandon Sim - President & CEO Chan Basho - CFO, COO & Corporate Secretary Conference Call Participants Jailendra Singh - Truist Securities, Inc., Research Division Matthew Mardula - William Blair & Company L.L.C., Research Division Meghan Holtz - Jefferies LLC, Research Division Michael Ha Ryan Langston - TD Cowen, Research Division Thomas Walsh David Larsen - BTIG, LLC, Research Division Craig Jones - BofA Securities, Research Division Zachary Haggerty Eugene Mannheimer - Prime Executions, Inc., Research Division Presentation Operator Good day, everyone, and welcome to Astrana Health Third Quarter 2025 Earnings Call.
Astrana Health, Inc. (ASTH) Misses Q3 Earnings Estimates
Astrana Health, Inc. (ASTH) came out with quarterly earnings of $0.01 per share, missing the Zacks Consensus Estimate of $0.47 per share. This compares to earnings of $0.33 per share a year ago.
ASTH or USPH: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Astrana Health, Inc. (ASTH) and U.S. Physical Therapy (USPH). But which of these two stocks offers value investors a better bang for their buck right now?
Astrana Health, Inc. (ASTH) Q2 2025 Earnings Call Transcript
Astrana Health, Inc. (ASHT) Q2 2025 Earnings Conference Call August 7, 2025 5:30 PM ET Company Participants Brandon K. Sim - President & CEO Chandan Basho - CFO, COO & Corporate Secretary Conference Call Participants Andrew Mok - Barclays Bank PLC, Research Division Craig Jones - BofA Securities, Research Division David Michael Larsen - BTIG, LLC, Research Division Hua Ha - Robert W.
Astrana Health, Inc. (ASTH) Q2 Earnings Lag Estimates
Astrana Health, Inc. (ASTH) came out with quarterly earnings of $0.19 per share, missing the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $0.4 per share a year ago.
Power Up Your Portfolio Value With These 5 High Earnings Yield Stocks
Value investors can consider buying high earnings yield stocks like B, ASTH, STNE, PHIN and PAGP for handsome returns.
ASTH vs. CHE: Which Stock Is the Better Value Option?
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Astrana Health, Inc. (ASTH) and Chemed (CHE). But which of these two stocks offers value investors a better bang for their buck right now?
Wall Street Analysts Think Astrana Health, Inc. (ASTH) Could Surge 97.29%: Read This Before Placing a Bet
The average of price targets set by Wall Street analysts indicates a potential upside of 97.3% in Astrana Health, Inc. (ASTH). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
All You Need to Know About Astrana Health, Inc. (ASTH) Rating Upgrade to Strong Buy
Astrana Health, Inc. (ASTH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
ASTH or CHE: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either Astrana Health, Inc. (ASTH) or Chemed (CHE). But which of these two stocks offers value investors a better bang for their buck right now?
Tap These 5 Bargain Stocks With Alluring EV-to-EBITDA Ratio
ASTH, KT, UPBD, NOAH and DXPE stand out with low EV-to-EBITDA ratios and strong 2025 earnings growth forecasts.
